How should intertriginous dermatitis be treated?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 18, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Treatment of Intertriginous Dermatitis

The cornerstone of treating intertriginous dermatitis is keeping affected skin folds dry and friction-free, combined with low-potency topical corticosteroids and treatment of secondary infections when present 1, 2.

Initial Assessment and Diagnosis

First, determine if secondary infection is present:

  • Look for satellite pustules → indicates candidal infection
  • Check for crusting or weeping → suggests bacterial infection
  • Assess for odor and exudate → markers of infection severity 3

Rule out other conditions that can mimic intertriginous dermatitis, particularly inverse psoriasis (look for well-demarcated plaques without satellite lesions) 4.

Treatment Algorithm

Step 1: Basic Skin Fold Management (All Patients)

  • Keep skin folds dry - this is non-negotiable and the most critical intervention 5, 6
  • Use soap-free cleansers instead of regular soap (soaps remove natural lipids and worsen the condition) 7
  • Apply barrier creams or emollients to reduce friction 2
  • Consider moisture-wicking textiles (such as silver-impregnated fabrics) placed within skin folds - these have shown significant improvements in skin damage, exudate, odor, and moisture 3, 5

Critical pitfall to avoid: Do NOT use bed linens, paper towels, or standard dressings to separate skin folds - these trap moisture and worsen the condition 2.

Step 2: Topical Corticosteroids

  • Use low-potency topical corticosteroids (hydrocortisone) for intertriginous areas 1, 4, 8
  • Apply once to twice daily
  • Never use high-potency steroids in skin folds - the occlusive nature of these areas dramatically increases absorption and risk of atrophy 4

The evidence strongly supports low-potency agents because skin in intertriginous areas is thin and naturally occluded, making it highly susceptible to steroid-induced atrophy 4, 8.

Step 3: Treat Secondary Infections

If candidal infection present (satellite pustules, positive KOH):

  • Topical azoles (clotrimazole, miconazole) or nystatin 1
  • Apply twice daily for 7-14 days
  • Continue even after visible improvement to ensure mycological cure

If bacterial infection present (crusting, weeping, odor):

  • Consider topical or oral antibiotics based on severity 9
  • For moderate to severe cases, some evidence supports 0.25% acetic acid combined with topical steroids 9

Step 4: Alternative Agents for Steroid-Sparing

Topical calcineurin inhibitors (tacrolimus 0.1% or pimecrolimus 1%):

  • Particularly useful for facial and intertriginous psoriasis - 65-71% clearance rates 8
  • Apply twice daily
  • Main side effect is burning/itching that typically improves with continued use
  • Advantage: No risk of skin atrophy, making them ideal for long-term management in skin folds 8

Ongoing Management

  • Address predisposing factors: obesity, diabetes, incontinence, excessive sweating 5, 6
  • Establish a structured skin care routine with regular cleansing using soap substitutes and barrier cream application 5
  • For recurrent cases, consider proactive maintenance with intermittent low-potency topical corticosteroids or calcineurin inhibitors 10

When to Escalate

If no improvement after 2-4 weeks of appropriate therapy:

  • Reconsider the diagnosis (could be inverse psoriasis, allergic contact dermatitis, or cutaneous lymphoma) 11
  • Perform skin biopsy if diagnosis uncertain
  • Consider dermatology referral for patch testing if allergic contact dermatitis suspected 10, 12

Key Clinical Pearls

The combination approach of moisture control + low-potency topical corticosteroids + treatment of secondary infection addresses all three pathogenic factors: friction, inflammation, and microbial overgrowth. Moisture-wicking textiles represent an evidence-based adjunct that significantly accelerates healing in hospitalized patients 3. The most common treatment failure occurs from using inappropriately potent steroids or failing to adequately address moisture and friction in the affected skin folds.

References

Guideline

guidelines for treatment of candidiasis.

Clinical Infectious Diseases, 2004

Research

MASD part 2: incontinence-associated dermatitis and intertriginous dermatitis: a consensus.

Journal of wound, ostomy, and continence nursing : official publication of The Wound, Ostomy and Continence Nurses Society, 2011

Research

Efficacy of a Moisture-Wicking, Silver-Impregnated Textile in Hospitalized Patients With Intertriginous Dermatitis (ITD): A Single-Case Experiment.

Journal of wound, ostomy, and continence nursing : official publication of The Wound, Ostomy and Continence Nurses Society, 2026

Research

Intertrigo: causes, prevention and management.

British journal of nursing (Mark Allen Publishing), 2020

Research

A Novel Approach to Treating Moderate to Severe Incontinence-Associated Dermatitis and Intertriginous Dermatitis: A Case Series.

Journal of wound, ostomy, and continence nursing : official publication of The Wound, Ostomy and Continence Nurses Society, 2019

Guideline

guidelines for the management of contact dermatitis: an update.

British Journal of Dermatology, 2009

Guideline

focused update: guidelines of care for the management of atopic dermatitis in adults.

Journal of the American Academy of Dermatology, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.